384 related articles for article (PubMed ID: 23800641)
1. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.
Zimmerman HA; Olson KC; Chen G; Lynch CJ
Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641
[TBL] [Abstract][Full Text] [Related]
2. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism.
She P; Van Horn C; Reid T; Hutson SM; Cooney RN; Lynch CJ
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1552-63. PubMed ID: 17925455
[TBL] [Abstract][Full Text] [Related]
3. Divergent Induction of Branched-Chain Aminotransferases and Phosphorylation of Branched Chain Keto-Acid Dehydrogenase Is a Potential Mechanism Coupling Branched-Chain Keto-Acid-Mediated-Astrocyte Activation to Branched-Chain Amino Acid Depletion-Mediated Cognitive Deficit after Traumatic Brain Injury.
Xing G; Ren M; Verma A
J Neurotrauma; 2018 Oct; 35(20):2482-2494. PubMed ID: 29764289
[TBL] [Abstract][Full Text] [Related]
4. Alloisoleucine differentiates the branched-chain aminoacidemia of Zucker and dietary obese rats.
Olson KC; Chen G; Xu Y; Hajnal A; Lynch CJ
Obesity (Silver Spring); 2014 May; 22(5):1212-5. PubMed ID: 24415721
[TBL] [Abstract][Full Text] [Related]
5. Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.
Wang XL; Li CJ; Xing Y; Yang YH; Jia JP
J Inherit Metab Dis; 2015 Sep; 38(5):855-61. PubMed ID: 25653144
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
[TBL] [Abstract][Full Text] [Related]
7. Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice.
Lian K; Du C; Liu Y; Zhu D; Yan W; Zhang H; Hong Z; Liu P; Zhang L; Pei H; Zhang J; Gao C; Xin C; Cheng H; Xiong L; Tao L
Diabetes; 2015 Jan; 64(1):49-59. PubMed ID: 25071024
[TBL] [Abstract][Full Text] [Related]
8. Living related versus deceased donor liver transplantation for maple syrup urine disease.
Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
[TBL] [Abstract][Full Text] [Related]
9. Expression of mitochondrial branched-chain aminotransferase and α-keto-acid dehydrogenase in rat brain: implications for neurotransmitter metabolism.
Cole JT; Sweatt AJ; Hutson SM
Front Neuroanat; 2012; 6():18. PubMed ID: 22654736
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.
Burrage LC; Nagamani SC; Campeau PM; Lee BH
Hum Mol Genet; 2014 Sep; 23(R1):R1-8. PubMed ID: 24651065
[TBL] [Abstract][Full Text] [Related]
11. PPM1K defects cause mild maple syrup urine disease: The second case in the literature.
Ozcelik F; Arslan S; Ozguc Caliskan B; Kardas F; Ozkul Y; Dundar M
Am J Med Genet A; 2023 May; 191(5):1360-1365. PubMed ID: 36706222
[TBL] [Abstract][Full Text] [Related]
12. Developmental Defects of Caenorhabditis elegans Lacking Branched-chain α-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency.
Jia F; Cui M; Than MT; Han M
J Biol Chem; 2016 Feb; 291(6):2967-73. PubMed ID: 26683372
[TBL] [Abstract][Full Text] [Related]
13. A novel regulatory defect in the branched-chain α-keto acid dehydrogenase complex due to a mutation in the PPM1K gene causes a mild variant phenotype of maple syrup urine disease.
Oyarzabal A; Martínez-Pardo M; Merinero B; Navarrete R; Desviat LR; Ugarte M; Rodríguez-Pombo P
Hum Mutat; 2013 Feb; 34(2):355-62. PubMed ID: 23086801
[TBL] [Abstract][Full Text] [Related]
14. Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease.
Mitsubuchi H; Owada M; Endo F
J Nutr; 2005 Jun; 135(6 Suppl):1565S-70S. PubMed ID: 15930470
[TBL] [Abstract][Full Text] [Related]
15. Phenylbutyrate therapy for maple syrup urine disease.
Brunetti-Pierri N; Lanpher B; Erez A; Ananieva EA; Islam M; Marini JC; Sun Q; Yu C; Hegde M; Li J; Wynn RM; Chuang DT; Hutson S; Lee B
Hum Mol Genet; 2011 Feb; 20(4):631-40. PubMed ID: 21098507
[TBL] [Abstract][Full Text] [Related]
16. Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model.
Greig JA; Jennis M; Dandekar A; Chorazeczewski JK; Smith MK; Ashley SN; Yan H; Wilson JM
Mol Genet Metab; 2021; 134(1-2):139-146. PubMed ID: 34454844
[TBL] [Abstract][Full Text] [Related]
17. Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves.
Sweatt AJ; Wood M; Suryawan A; Wallin R; Willingham MC; Hutson SM
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E64-76. PubMed ID: 12965870
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells.
Lu G; Sun H; She P; Youn JY; Warburton S; Ping P; Vondriska TM; Cai H; Lynch CJ; Wang Y
J Clin Invest; 2009 Jun; 119(6):1678-87. PubMed ID: 19411760
[TBL] [Abstract][Full Text] [Related]
19. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
